ORLANDI, Martina
 Distribuzione geografica
Continente #
AS - Asia 4.758
NA - Nord America 3.334
EU - Europa 1.295
SA - Sud America 572
AF - Africa 85
OC - Oceania 6
Continente sconosciuto - Info sul continente non disponibili 1
Totale 10.051
Nazione #
US - Stati Uniti d'America 3.203
CN - Cina 1.680
SG - Singapore 1.369
IT - Italia 491
VN - Vietnam 447
BR - Brasile 429
HK - Hong Kong 412
KR - Corea 292
BD - Bangladesh 217
GB - Regno Unito 209
RU - Federazione Russa 122
IN - India 94
FI - Finlandia 93
FR - Francia 86
DE - Germania 74
CA - Canada 59
AR - Argentina 52
ID - Indonesia 50
NL - Olanda 50
MX - Messico 40
LT - Lituania 31
EC - Ecuador 30
IQ - Iraq 26
ZA - Sudafrica 23
PK - Pakistan 22
JP - Giappone 20
SE - Svezia 20
AE - Emirati Arabi Uniti 19
TR - Turchia 19
PL - Polonia 18
AT - Austria 17
ES - Italia 17
VE - Venezuela 16
PY - Paraguay 15
CO - Colombia 14
MA - Marocco 13
EG - Egitto 12
UA - Ucraina 12
PH - Filippine 10
SA - Arabia Saudita 10
TN - Tunisia 10
UZ - Uzbekistan 10
BE - Belgio 9
JO - Giordania 7
CL - Cile 6
DZ - Algeria 6
KZ - Kazakistan 6
RO - Romania 6
AZ - Azerbaigian 5
CR - Costa Rica 5
GR - Grecia 5
GT - Guatemala 5
KE - Kenya 5
MY - Malesia 5
NP - Nepal 5
AU - Australia 4
CZ - Repubblica Ceca 4
DK - Danimarca 4
GE - Georgia 4
KG - Kirghizistan 4
PA - Panama 4
PE - Perù 4
SY - Repubblica araba siriana 4
TH - Thailandia 4
UY - Uruguay 4
AL - Albania 3
BY - Bielorussia 3
ET - Etiopia 3
KW - Kuwait 3
NI - Nicaragua 3
PS - Palestinian Territory 3
PT - Portogallo 3
SV - El Salvador 3
TW - Taiwan 3
AO - Angola 2
BB - Barbados 2
BG - Bulgaria 2
BO - Bolivia 2
DO - Repubblica Dominicana 2
EE - Estonia 2
HN - Honduras 2
HU - Ungheria 2
IE - Irlanda 2
JM - Giamaica 2
MD - Moldavia 2
NG - Nigeria 2
SI - Slovenia 2
SK - Slovacchia (Repubblica Slovacca) 2
SN - Senegal 2
UG - Uganda 2
BA - Bosnia-Erzegovina 1
BH - Bahrain 1
BS - Bahamas 1
BW - Botswana 1
BZ - Belize 1
CI - Costa d'Avorio 1
CW - ???statistics.table.value.countryCode.CW??? 1
IL - Israele 1
IR - Iran 1
KH - Cambogia 1
Totale 10.037
Città #
Hefei 1.021
Santa Clara 872
Singapore 752
Ashburn 497
Hong Kong 408
San Jose 407
Seoul 290
Council Bluffs 175
Ho Chi Minh City 168
London 157
Beijing 105
Hanoi 105
Los Angeles 90
The Dalles 90
New York 87
Lauterbourg 66
Buffalo 61
Chicago 61
Helsinki 61
Kent 59
Milan 58
São Paulo 44
Boardman 40
Dallas 38
Jakarta 32
Rome 31
Moscow 30
Orem 28
Bologna 27
Munich 27
Florence 26
Salt Lake City 25
Haiphong 22
Lappeenranta 22
Ovada 22
Amsterdam 21
Da Nang 21
Shanghai 19
Brooklyn 18
Chennai 18
Naples 18
Guangzhou 17
Montreal 17
Parma 15
Turin 15
Warsaw 15
Baghdad 13
Quito 13
Charlotte 12
Mexico City 12
Modena 12
Nuremberg 12
Rio de Janeiro 12
Schiffdorf 12
Dubai 11
Hillsboro 11
Johannesburg 11
Reggio Emilia 11
Toronto 11
Atlanta 10
Brasília 10
Manchester 10
Tampa 10
Trieste 10
Turku 10
Denver 9
Lancaster 9
North Bergen 9
Poplar 9
San Francisco 9
Tokyo 9
Biên Hòa 8
Boston 8
Elk Grove Village 8
Guarulhos 8
Mumbai 8
Sterling 8
Tashkent 8
Amman 7
Asunción 7
Bari 7
Belo Horizonte 7
Campinas 7
Formigine 7
Frankfurt am Main 7
Guiyang 7
Houston 7
New Delhi 7
Ninh Bình 7
Philadelphia 7
Stockholm 7
Venice 7
Zhengzhou 7
Ankara 6
Buenos Aires 6
Bến Tre 6
Can Tho 6
Casablanca 6
Charleston 6
Curitiba 6
Totale 6.668
Nome #
The predictive role of the TAPSE/sPAP ratio for cardiovascular events and mortality in systemic sclerosis with pulmonary hypertension 207
MENSTRUATION-RELATED DISORDERS IN WOMAN WITH RHEUMATIC DISEASE (RDS): BLEEDING AND PAIN 197
ORAL MANIFESTATIONS IN SYSTEMICSCLEROSIS: CLINICAL EVALUATION OF APERSONAL CASE SERIES OF 13 SCLERODERMAPATIENTS 195
Clinical Presentation of Connective Tissue Disease Patients with and without Interstitial Lung Disease: A Retrospective Study 189
Ultrashort Echo-Time Magnetic Resonance Imaging Sequence in the Assessment of Systemic Sclerosis-Interstitial Lung Disease 188
A New Promising Role for Selexipag in the Treatment of Scleroderma Vasculopathy: Preliminary Results From a Third Level Italian Scleroderma Center 175
THE PREDICTIVE ROLE OF THE TAPSE/sPAP RATIO FOR CARDIOVASCULAR EVENTS AND MORTALITY IN SYSTEMIC SCLEROSIS COMPLICATED BY PULMONARY HYPERTENSION 170
ENDOMETRIOSI E MALATTIE REUMATICHE: LA PUNTA DELL’ICEBERG DEI NUMEROSI DISTURBI MESTRUALI IN CORSO DI MALATTIA REUMATICA 168
Pleuroparenchymal fibroelastosis in rheumatic autoimmune diseases: a systematic literature review 166
Computed Tomography Predictors of Mortality or Disease Progression in Systemic Sclerosis–Interstitial Lung Disease: A Systematic Review 163
Chest radiography findings of COVID-19 pneumonia: a specific pattern for a confident differential diagnosis 151
Secondary cryofibrinogenemia is related to more severe microangiopathic involvement in systemic sclerosis: results from a retrospective observational study. 151
A three-dimensional measurement method on MR arthrography of the hip to classify femoro-acetabular impingement 150
A manual therapy intervention improves symptoms in patients with carpal tunnel syndrome: a pilot study 149
Secondary cryofbrinogenemia is related to more severe microangiopathic involvement in systemic sclerosis: results from a retrospective observational study 144
The Role of Bronchoalveolar Lavage in Systemic Sclerosis Interstitial Lung Disease: A Systematic Literature Review 143
Lung ultrasound B-lines in systemic sclerosis: cut-off values and methodological indications for interstitial lung disease screening 141
The role of chest CT in deciphering interstitial lung involvement: systemic sclerosis versus COVID-19 140
Potential Role of JAK Inhibitors in the Treatment of Systemic Sclerosis-Associated Interstitial Lung Disease: A Narrative Review from Pathogenesis to Real-Life Data 138
Role of COVID-19 in the progression of scleroderma interstitial lung disease and new onset pulmonary hypertension: a challenging case report. 137
THE FIRST 1000 DAYS OF LIFE AND REPRODUCTIVE DISORDERS IN WOMAN WITH RHEUMATIC DISEASE (RDS) 136
The Yin-Yang Pharmacomicrobiomics on Treatment Response in Inflammatory Arthritides: A Narrative Review 135
Mindfulness Program in Sjögren's Syndrome and Non-Sjögren's Sicca Syndrome Patients: A Pilot Study on Quality of Life and Psychological Distress 135
How radiology can help pulmonary tuberculosis diagnosis: analysis of 49 patients 134
Lung Ultrasound B-Lines in the Evaluation of the Extent of Interstitial Lung Disease in Systemic Sclerosis 134
VULVAR HISTOPATHOLOGICAL AND IMMUNOHISTOCHEMICAL CHANGES IN PATIENTS WITH PRIMARY SJÖGREN SYNDROME 133
Doubts and concerns about COVID-19 uncertainties on imaging data, clinical score, and outcomes 131
BMP-4 and fetuin A in systemic sclerosis patients with or without calcinosis 131
Radiological patterns and pulmonary function values of lung involvement in primary Sjögren’s syndrome: A pilot analysis 130
Women with primary sjögren syndrome and with Non-Sjögren Sicca syndrome show similar vulvar histopathologic and immunohistochemical changes 130
MYCOPHENOLATE MOFETIL TREATMENT REDUCES THE RISK OF TREATMENT ESCALATION DUE TO VASCULAR COMPLICATIONS IN LIMITED CUTANEOUS SYSTEMIC SCLEROSIS: EMULATION OF A TARGET TRIAL FROM ITALIAN RHEUMATOLOGY SOCIETY SPRING REGISTRY 129
L’IPERTENSIONE POLMONARE: DALLE NUOVE LINEE GUIDA ALLA PRATICA CLINICA 129
Towards a comprehensive approach to the management and prognosis of systemic sclerosis's patients: The role of comorbidities in the SPRING-SIR registry 128
Clinical, morphological features and prognostic factors associated with interstitial lung disease in primary Sjӧgren's syndrome: A systematic review from the Italian Society of Rheumatology 127
Artificial Intelligence and Radiomics at the University of Florence 125
Clinical and histological features of patients with primary Sjӧgren’s syndrome and autoimmune thyroiditis: a national multicentre cross-sectional study 124
CT evaluation of interstitial lung disease related to systemic sclerosis: visual versus automated assessment. A systematic review 124
Feasibility, face, and content validity of quantitative computed tomography in interstitial lung disease related to connective tissue diseases 122
Gynaecological symptoms and sexual disability in women with primary Sjögren's syndrome and sicca syndrome 121
Sjögren's syndrome: one year in review 2023 119
Menstruation-Related Disorders-Dysmenorrhea and Heavy Bleeding-as Significant Epiphenomena in Women With Rheumatic Diseases 118
Systemic sclerosis: one year in review 2022 116
Doppler ultrasound unveils splanchnic arteries ischemia allowing early successful revascularization in symptomatic systemic sclerosis patients 115
Morphological, Functional and Texture Analysis Magnetic Resonance Imaging Features in the Assessment of Radiotherapy-Induced Xerostomia in Oropharyngeal Cancer 114
The Role of Imaging in COVID-19 Pneumonia Diagnosis and Management: Main Positions of the Experts, Key Imaging Features and Open Answers 113
Advanced and traditional chest MRI sequence for the clinical assessment of systemic sclerosis related interstitial lung disease, compared to CT: disease extent analysis and correlations with pulmonary function tests 112
Pulmonary Arterial Hypertension Incidence in Patients With Systemic Sclerosis Treated With Bosentan for Digital Ulcers: Evidence From the SPRING-SIR Registry. 109
Long-term effects of selexipag in systemic sclerosis-associated digital ulcers: a case control multicentre observational study 108
Sjögren's syndrome: state of the art on clinical practice guidelines 108
One year in review 2015: spondyloarthritis 107
The positive side of the coin: Sars-Cov-2 pandemic has taught us how much Telemedicine is useful as standard of care procedure in real life 107
Techniques, Tricks, and Stratagems of Oral Cavity Computed Tomography and Magnetic Resonance Imaging 106
Ischemia–hyperpnea test is useful to detect patients with Fibromyalgia syndrome 106
The importance of body image and aesthetic medicine in systemic sclerosis 104
Myositis-Specific and Myositis-Associated Antibodies in Fibromyalgia Patients: A Prospective Study 102
Prevalence and clinical relevance of digital ulcers in systemic sclerosis patients from the real-life: the experience of the SPRING Registry of the Italian Society for Rheumatology 101
The Performance of Pulmonary Function Tests in Predicting Systemic Sclerosis—Interstitial Lung Disease in the European Scleroderma Trial and Research Database 100
Pleuroparenchymal fibroelastosis in patients affected by systemic sclerosis: What should the rheumatologist do? 99
Sintomi Ginecologici E Disabilità Sessuale In Donne Con Sindrome Di Sjögren Primaria E Sindrome Sicca 98
“Usual” interstitial pneumonia with autoimmune features: a prospective study on a cohort of idiopathic pulmonary fibrosis patients 96
The emerging challenge of pain in systemic sclerosis: Similarity to the pain experience reported by Sjogren's syndrome patients 96
One year in review 2019: Sjögren’s syndrome 96
The COVID-19 pandemic highlights the need for a psychological support in systemic sclerosis patients 96
Ultrasound evaluation of bowel vasculopathy in systemic sclerosis 94
First-line diagnostic tests to intercept primary heart involvement in systemic sclerosis: Clinical associations from the SPRING-SIR registry 94
Infection or autoimmunity? The clinical challenge of interstitial lung disease in systemic sclerosis during the COVID-19 pandemic 92
One year in review 2017: primary Sjögren's syndrome 91
One year in review 2018: Systemic sclerosis 90
Prevalence of sacroiliitis on magnetic resonance enterography in Crohn's disease and its association with intestinal findings: a monocentric observational cross-sectional study 89
One year in review 2021: systemic sclerosis 87
Quantitative chest tomography indexes are related to disease activity in systemic sclerosis: results from a cross-sectional study 86
Patients with interstitial lung disease secondary to autoimmune diseases: How to recognize them? 86
Mindfulness Meditation: An Interesting Opportunity for the Rheumatologist 86
Elderly-onset systemic sclerosis defines a distinct clinical subset: analysis from the SPRING registry of the Italian Society for Rheumatology 85
The role of lung biopsy for diagnosis and prognosis of interstitial lung disease in systemic sclerosis: a systematic literature review 80
One year in review 2019: Systemic sclerosis 79
The systemic sclerosis patient in the COVID-19 era: the challenging crossroad between immunosuppression, differential diagnosis and long-term psychological distress 78
One year in review 2020: Systemic sclerosis 77
One year in review 2016: idiopathic inflammatory myopathies 74
One year in review 2017: Systemic sclerosis 72
Pulmonary magnetic resonance imaging in systemic sclerosis: a jump in the future to unravel inflammation in interstitial lung disease 68
Risk of malignancy and biologic therapy in rheumatic inflammatory diseases: A single-center experience 61
Menopause in systemic sclerosis: the impact on clinical presentation in a multicenter cross-sectional analysis from the National Registry of the Italian Society for Rheumatology (SPRING-SIR) 47
Beyond systemic lupus erythematosus: a systematic review on the use of belimumab in other connective tissue diseases and vasculitides 46
Optical coherence tomography angiography: a window on systemic sclerosis microangiopathy 45
Gastrointestinal involvement in very early and established systemic sclerosis: insights from the SPRING-SIR national Italian registry. 44
Prevalence, distribution and associations of the scleroderma capillaroscopic patterns: new insights from the Italian SPRING-SIR registry 38
Exploring Disease-Specific Risk Factors for Vertebral Fractures in Systemic Sclerosis: Insights from the ScleroRER Study Group 28
Age and onset timing of Raynaud’s phenomenon and first non-Raynaud symptom as prognostic factors in systemic sclerosis: a retrospective analysis from the Italian national multicenter Systemic Sclerosis Progression INvestiGation registry of the Italian Society for Rheumatology (SPRING-SIR) 26
Comment on: Long-term effects of selexipag in SSc-associated digital ulcers: a case-control multicentre observational study: reply 22
The clinical profile of systemic sclerosis without a ‘scleroderma pattern’ at nailfold capillaroscopy: results from the multicenter SPRING registry of the Italian Society of Rheumatology 10
Clinical and serological features of triple autoantibody-­ negative patients with systemic sclerosis: insights from the multicentric SPRING registry of the Italian Society for Rheumatology 7
Totale 10.148
Categoria #
all - tutte 39.783
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 39.783


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2023/2024259 0 0 37 48 38 19 10 18 9 10 30 40
2024/20253.056 68 11 17 178 628 407 127 206 339 211 466 398
2025/20266.701 630 521 743 767 598 317 765 331 557 584 554 334
2026/2027132 132 0 0 0 0 0 0 0 0 0 0 0
Totale 10.148